Dr. Lal Path Labs Ltd. has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has informed the exchanges that its trading window for dealing in company securities will be closed starting July 1, 2025. The window will reopen 48 hours after the announcement of financial results for the quarter ending June 30, 2025 (Q1 FY26). This is a standard compliance filing under SEBI's Insider Trading Regulations to prevent insider trading ahead of the quarterly results announcement. The intimation was signed by Vinay Gujral, Company Secretary and Compliance Officer, on June 26, 2025.
No direct impact on shareholders or stock price. This is a routine regulatory disclosure indicating that Q1 FY26 results are likely to be announced in the coming weeks, which investors should watch for as it could influence short-term price movement.